| 1 | Systemic lipid remodeling associated with deferoxamine treatment, dietary intervention and combinatorial effect in ameliorating high cholesterol diet-induced steatotic liver in mice. (Ni Z, Wang R, Miao H, Wang G, Lim WLF, Zhang S, Lam SM, Shui G) Free Radic Biol Med 2026 May;248:436-449 1 Citation |
| 2 | Discovery of a MET -driven monogenic cause of steatotic liver disease. (Pinto E Vairo F, Zimmermann MT, Wagenknecht J, Jorge SD, Tian S, Vierkant RA, Luehrs AC, Milech de Assunção T, Mathison A, Atwal PS, Cao Y, Allen AM, Klee EW, Urrutia R, Lazaridis KN) Hepatology 2025 Dec 01;82(6):1512-1522 2 Citations |
| 4 | A serum-induced gene signature in hepatocytes is associated with pediatric nonalcoholic fatty liver disease. (Hang Nghiem-Rao T, Johnson JS, Pan A, Atkinson SN, Behling C, Simpson PM, Holtz ML, Weinstock GM, Schwimmer JB, Salzman NH) J Pediatr Gastroenterol Nutr 2024 Apr;78(4):886-897 2 Citations |
| 1 | Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma. (Rajendran L, Murillo Perez CF, Ivanics T, Claasen MPAW, Hansen BE, Wallace D, Yoon PD, Sapisochin G) HPB (Oxford) 2023 May;25(5):556-567 12 Citations |
| 1 | CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. (Shi H, Wang X, Li F, Gerlach BD, Yurdagul A Jr, Moore MP, Zeldin S, Zhang H, Cai B, Zheng Z, Valenti L, Tabas I) Sci Transl Med 2022 Nov 23;14(672):eabp8309 74 Citations |
| 1 | Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies. (Hur WS, King KC, Patel YN, Nguyen YV, Wei Z, Yang Y, Juang LJ, Leung J, Kastrup CJ, Wolberg AS, Luyendyk JP, Flick MJ) J Thromb Haemost 2022 Dec;20(12):2873-2886 17 Citations |
| 1 | The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children. (Chaidez A, Pan Z, Sundaram SS, Boster J, Lovell M, Sokol RJ, Mack CL) Hepatol Commun 2022 Nov;6(11):3015-3023 38 Citations |
| 1 | Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. (Ochoa-Rios S, O'Connor IP, Kent LN, Clouse JM, Hadjiyannis Y, Koivisto C, Pecot T, Angel PM, Drake RR, Leone G, Mehta AS, Rockey DC) Mol Cell Proteomics 2022 May;21(5):100225 20 Citations |
| 1 | Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring. (Fu Q, North PE, Ke X, Huang YW, Fritz KA, Majnik AV, Lane RH) J Nutr 2021 Oct 01;151(10):3102-3112 5 Citations |
| 1 | Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease. (Khayat A, Vitola B) J Pediatr 2021 Dec;239:155-160 16 Citations |
| 1 | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. (Motamed N, Nikkhah M, Karbalaie Niya MH, Khoonsari M, Perumal D, Ashrafi GH, Faraji AH, Maadi M, Ajdarkosh H, Safarnezhad Tameshkel F, Moradi-Lakeh M, Miri SM, Arsang-Jang S, Zamani F) Clin Res Hepatol Gastroenterol 2021 Nov;45(6):101567 22 Citations |
| 1 | A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. (Bashyam A, Frangieh CJ, Raigani S, Sogo J, Bronson RT, Uygun K, Yeh H, Ausiello DA, Cima MJ) Nat Biomed Eng 2021 Mar;5(3):240-251 24 Citations |
| 1 | Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease. (Xiao Y, Kim M, Lazar MA) Mol Metab 2021 Aug;50:101119 38 Citations |
| 1 | A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction. (Satapathy SK, Gonzalez HC, Vanatta J, Dyer A, Angel W, Nouer SS, Kocak M, Kedia SK, Jiang Y, Clark I, Yadak N, Nezakagtoo N, Helmick R, Horton P, Campos L, Agbim U, Maliakkal B, Maluf D, Nair S, Halford HH, Eason JD) PLoS One 2020;15(5):e0232006 4 Citations |
| 1 | Hepatic Artery Thrombosis and Takotsubo Syndrome After Liver Transplantation - Which Came First? (Luu LA, Rawashdeh B, Goldaracena N, Agarwal A, McCracken EK, Sahli ZT, Oberholzer J, Pelletier SJ) Am J Case Rep 2020 Apr 14;21:e920263 6 Citations |
| 1 | Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. (Wang X, Cai B, Yang X, Sonubi OO, Zheng Z, Ramakrishnan R, Shi H, Valenti L, Pajvani UB, Sandhu J, Infante RE, Radhakrishnan A, Covey DF, Guan KL, Buck J, Levin LR, Tontonoz P, Schwabe RF, Tabas I) Cell Metab 2020 May 05;31(5):969-986.e7 177 Citations |
| 1 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials. (Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z, STELLAR-3, STELLAR-4 Investigators) J Hepatol 2020 Jul;73(1):26-39 459 Citations |
| 1 | Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. (Cai B, Dongiovanni P, Corey KE, Wang X, Shmarakov IO, Zheng Z, Kasikara C, Davra V, Meroni M, Chung RT, Rothlin CV, Schwabe RF, Blaner WS, Birge RB, Valenti L, Tabas I) Cell Metab 2020 Feb 04;31(2):406-421.e7 237 Citations |
| 1 | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. (Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, Bross C, Durelle J, Goyal NP, Hamilton G, Holtz ML, Lavine JE, Mitreva M, Newton KP, Pan A, Simpson PM, Sirlin CB, Sodergren E, Tyagi R, Yates KP, Weinstock GM, Salzman NH) Gastroenterology 2019 Oct;157(4):1109-1122 262 Citations |
| 1 | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. (Ren SM, Mei L, Huang H, Cao SF, Zhao RH, Zheng PY) Zhonghua Gan Zang Bing Za Zhi 2019 May 20;27(5):369-375 |
| 1 | Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis-Worth the Risk. (Waits SA, Sheetz KH, Ghaferi AA) JAMA Netw Open 2019 Feb 01;2(2):e190053 4 Citations |
| 1 | Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. (Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A, Ghosh S, Patnaik S, Ghosh D, Mondal P) Nanomedicine 2019 Apr;17:210-222 57 Citations |
| 1 | HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. (Chandrashekaran V, Seth RK, Dattaroy D, Alhasson F, Ziolenka J, Carson J, Berger FG, Kalyanaraman B, Diehl AM, Chatterjee S) Redox Biol 2017 Oct;13:8-19 69 Citations |
| 1 | Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. (Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA) HPB (Oxford) 2017 Aug;19(8):706-712 6 Citations |
| 1 | Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. (Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, Charlton M) Gastroenterology 2017 Apr;152(5):1090-1099.e1 491 Citations |
| 3 | Serotonin Syndrome Resulting From Acute Decompensation of Nonalcoholic Steatohepatitis Cirrhosis in a Patient Chronically Treated With Citalopram and Tramadol. (Gollapudy S, Cronin DC, Pagel PS, Boettcher BT) J Cardiothorac Vasc Anesth 2017 Aug;31(4):1385-1388 3 Citations |
| 1 | Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. (Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S) Cytokine 2016 Jun;82:102-11 65 Citations |
| 1 | Reply: To PMID 25479138. (Shteyer E, Smith B) Gastroenterology 2015 Jul;149(1):261-2 |
| 1 | NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. (Das S, Alhasson F, Dattaroy D, Pourhoseini S, Seth RK, Nagarkatti M, Nagarkatti PS, Michelotti GA, Diehl AM, Kalyanaraman B, Chatterjee S) Am J Pathol 2015 Jul;185(7):1944-57 53 Citations |
| 2 | Truncating mutation in the nitric oxide synthase 1 gene is associated with infantile achalasia. (Shteyer E, Edvardson S, Wynia-Smith SL, Pierri CL, Zangen T, Hashavya S, Begin M, Yaacov B, Cinamon Y, Koplewitz BZ, Vromen A, Elpeleg O, Smith BC) Gastroenterology 2015 Mar;148(3):533-536.e4 40 Citations |
| 1 | Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. (Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, Magkos F, Klein S) J Pediatr 2013 Jun;162(6):1160-8, 1168.e1 67 Citations |
| 1 | Predictors of nonalcoholic steatohepatitis in obese children. (Lerret SM, Garcia-Rodriguez L, Skelton J, Biank V, Kilway D, Telega G) Gastroenterol Nurs 2011;34(6):434-7 9 Citations |
| 1 | The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. (Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB) J Surg Res 2011 Jul;169(1):e7-14 14 Citations |
| 1 | Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. (Gawrieh S, Knoedler DM, Saeian K, Wallace JR, Komorowski RA) Ann Diagn Pathol 2011 Feb;15(1):19-24 95 Citations |
